DexCom's Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's annual report on Form 10-K for the period ending December 31, 2006, as filed with the Securities and Exchange Commission on February 27, 2007, the company's quarterly report on Form 10-Q for the period ending September 30, 2007, as filed with the Securities and Exchange Commission on October 30, 2007, and its other filings with the Securities and Exchange Commission from time to time. Should one or more of these risks or uncertainties materialize, or should any of the company's assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. DexCom undertakes no obligation to publicly update or revise any forward-looking statements.
Contacts for Insulet Corporation
Mark Sahl, Lazar Partners for Insulet Corporation, Tel. +1-646-871-8485 or +1-609-992-5205
Paul Kidwell, Lazar Partners for Insulet Corporation, Tel. +1-617-296-3854 or +1-617-680-1088
Stephanie Marks for Insulet Corporation, 877-PODD-IR1 (877-763-3471) email@example.com
Contact for DexCom
|SOURCE Insulet Corporation|
Copyright©2008 PR Newswire.
All rights reserved